文献速递妇产影像腹部MR

子宫内膜癌患者MRI来源肌少症的预后意义

Prognostic significance of MRI-derived sarcopenia in patients with endometrial cancer.
PubMed 文献 · Abdom Radiol (NY) · 2025-08-06

回顾性队列纳入289例子宫内膜癌手术分期患者,以术前MRI第三腰椎总腰大肌面积最低四分位定义肌少症,并与289例年龄匹配健康女性对照;肌少症占24.9%,与子宫浆膜侵犯更常见相关,在多变量分析中为无病生存和总生存降低的独立预测因子。

要点

  • 术前MRI L3 TPMA最低四分位定义为肌少症,本研究EC患者中占24.9%(72/289)。
  • 肌少症患者子宫浆膜侵犯比例60.0% vs 非肌少症23.7%(p=0.018)。
  • 肌少症为DFS(p=0.023)和OS(p=0.035)降低的独立预测因子。

核心结论

  • MRI来源肌少症在EC患者中占24.9%,与不利病理特征独立相关,并与较差生存结局独立相关。

研究设计与样本

  • 回顾性队列研究纳入2009至2018年间接受手术分期的289例EC患者,并以289例年龄匹配健康女性作为对照。

关键影像表现/征象

  • 肌少症定义为术前MRI第三腰椎总腰大肌面积(L3 TPMA)最低四分位。
  • 肌少症患者L3 TPMA为642±110 mm²,非肌少症患者为1144±261 mm²,对照组为1029±258 mm²(p<0.001)。

诊断标准与关键数值

  • 肌少症判定标准:术前MRI L3 TPMA最低四分位,EC患者中检出率为24.9%(n=72/289)。
  • 子宫浆膜侵犯在肌少症患者中占60.0%,在非肌少症患者中占23.7%(p=0.018)。
  • 多变量分析显示肌少症为DFS降低的独立预测因子(p=0.023),并为OS降低的独立预测因子(p=0.035)。

临床应用与阅片要点

  • 可于术前MRI测量L3 TPMA,按最低四分位识别肌少症,辅助评估EC患者的预后风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the prognostic significance of MRI-derived sarcopenia in patients with endometrial cancer (EC), and to explore its association with clinicopathological features, treatment characteristics, and survival outcomes.

METHODS: This retrospective cohort study included 289 EC patients undergoing surgical staging between 2009 and 2018. Sarcopenia was measured as the lowest quartile of the third lumbar vertebra total psoas muscle area (L3 TPMA) on preoperative MRI. Associations between sarcopenia and pathological characteristics were evaluated using Pearson's Chi-square test or Fisher's exact test for categorical variables, and independent t-tests or Mann-Whitney U tests for continuous variables. To provide a contextual reference for sarcopenia-related parameters, 289 age-matched healthy women were retrospectively selected as controls. Kaplan-Meier and multivariate Cox proportional hazards analyses were conducted to assess the impact of sarcopenia on disease-free survival (DFS) and overall survival (OS).

RESULTS: Sarcopenia was identified in 24.9% (n = 72/289) of EC patients. Uterine serosal invasion was significantly more frequent in sarcopenic patients compared to non-sarcopenic patients (60.0% vs. 23.7%, p = 0.018). Adjuvant treatments, including chemotherapy, radiotherapy, and brachytherapy, did not significantly differ by sarcopenia status. L3 TPMA was significantly lower in sarcopenic patients (642 ± 110 mm²) compared to non-sarcopenic patients (1144 ± 261 mm²) and controls (1029 ± 258 mm²) (p < 0.001). In multivariate analysis, sarcopenia remained an independent predictor of both reduced DFS (p = 0.023) and OS (p = 0.035), along with FIGO 2023 stage, chemotherapy administration, and elevated CA-125 levels.

CONCLUSION: MRI-derived sarcopenia was identified in 24.9% of patients with EC and was independently associated with unfavorable pathological characteristics and poor survival outcomes.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Aybal T, Keles E, Kahyaoğlu B, et al. Prognostic significance of MRI-derived sarcopenia in patients with endometrial cancer. Abdom Radiol (NY). 2025. PMID: 40767944. doi:10.1007/s00261-025-05147-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。